Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Benjamin Bai
Building a robust trade secret strategy in China
Introduction As one of the largest markets in the world, China offers significant opportunities for multinational life sciences companies, including access to the Chinese market, world-leading research facilities, institutional and private Chinese investors and partners with manufacturing, distribution and other supply-chain expertise. Trade secrets can be worth tens or hundreds of millions of dollars.
Building a robust trade secret strategy in China as courts increasingly awarding significant damages
Introduction As one of the largest markets in the world, China offers significant opportunities for multinational life sciences companies, including access to the Chinese market, world-leading research facilities, institutional and private Chinese investors and partners with manufacturing, distribution and other supply chain expertise. Trade secrets can be worth tens or hundreds of millions of dollars.
Building a robust trade secret strategy in China
Introduction As one of the largest markets in the world, China offers significant opportunities for multinational life sciences companies, including access to the Chinese market, world-leading research facilities, institutional and private Chinese investors and partners with manufacturing, distribution and other supply chain expertise. Trade secrets can be worth tens or hundreds of millions of dollars.
IP experts remain positive in the face of changes to the global life sciences landscape
Contributors to the latest edition of the IAM Guide to Life Sciences stress that, while AI has the potential to revolutionise the global life sciences landscape, its integration in the pharma industry and the growing threat of cybersecurity breaches pose significant challenges to those operating in this space. However, there are many opportunities of which rights holders can take advantage.
Why crypto firms should embrace regulations and compliance
The crypto industry has come a long way since the launch of Bitcoin in 2009.
Analysing overseas trials for China’s covid-19 vaccines
Since the outbreak of the covid-19 pandemic, five vaccines have been approved for conditional marketing in China, namely inactivated vaccines developed by Sinopharm’s Beijing Institute of Biological Products, Sinopharm’s Wuhan Institute of Biological Products and Sinovac Biotech, the adenovirus vector vaccine developed by CanSino Biologics, and recombinant protein vaccine by Chongqing Zhifei Biological Products.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Benjamin
Contact Benjamin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack